Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the Apelin-APJ Axis: A Promising Strategy to Mitigate Anthracycline-Induced Cardiotoxicity. | Cardiovasc Toxicol | 2026 | 41995966 | PubTator, text mining | PubMed |
| Context‑dependent duality of the apelin/elabela‑APJ system in diabetes and its complications (Review). | Int J Mol Med | 2026 | 41992965 | PubTator, text mining | PubMed |
| A Novel Marker in Hypogonadal Hypogonadism: Apelin. | Sisli Etfal Hastan Tip Bul | 2026 | 41988064 | PubTator, text mining | PubMed |
| ELABELA Targets Mitochondria to Modulate Heart Development. | Adv Sci (Weinh) | 2026 | 41944334 | PubTator, text mining | PubMed |
| A bioengineered recombinant spider silk provides targeted G-protein-coupled receptor activation. | Acta Biomater | 2026 | 41933774 | PubTator, text mining | PubMed |
| Dynamic monomer-dimer transition in ligand-induced apelin receptor activation. | Nat Commun | 2026 | 41932888 | PubTator, text mining | PubMed |
| Cardiometabolic and Antioxidant Properties of Modified C-Terminal Fragments of Apelin in Experimental Cardiac Pathology. | Kardiologiia | 2026 | 41925178 | PubTator, text mining | PubMed |
| International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applications. | Pharmacol Rev | 2026 | 41895070 | PubTator, text mining | PubMed |
| Regenerative Approach for Improving Flap Survival: Perspective of Angiogenesis. | Biomimetics (Basel) | 2026 | 41892109 | PubTator, text mining | PubMed |
| Preeclampsia Diagnosis Using β-Hairpin Peptide for ELABELA Detection. | J Pept Sci | 2026 | 41891673 | PubTator, text mining | PubMed |
| Differential serum dynamics of apelin, elabela, and angiotensinogen in CKD and haemodialysis: insights into peptide modulation across the dialysis procedure. | Ren Fail | 2026 | 41888034 | PubTator, text mining | PubMed |
| Prognostic significance of serum apelin-13 and galectin-3 concentrations as potential indicators of severity and mortality in pediatric acute respiratory distress syndrome. | Turk J Pediatr | 2026 | 41871558 | PubTator, text mining | PubMed |
| Apelin/APJ Signalling as a Potential Complementary Target for Glucagon-like Peptide-1 Receptor Agonist Therapy in Heart Failure. | Card Fail Rev | 2026 | 41837114 | PubTator, text mining | PubMed |
| The Role of the Apelin Receptor in the Pathophysiology of Pulmonary Arterial Hypertension. | Cells | 2026 | 41827893 | PubTator, text mining | PubMed |
| Role of apelin as a biomarker in functional recovery and post-stroke-associated sarcopenia: insights from rehabilitation therapy. | PeerJ | 2026 | 41809696 | PubTator, text mining | PubMed |
| A dynamic bioreactor for endothelial and epithelial cell co-culture to mimic aspects of renal microenvironments. | Biomed Microdevices | 2026 | 41801461 | PubTator, text mining | PubMed |
| Emphasis on Associations Between Hsa_circ_0123190, Hsa-miR-483-3p, APLNR, and Key Serum Biomarkers HDAC1 and PUMA in Diabetic Nephropathy. | FASEB J | 2026 | 41801243 | PubTator, text mining | PubMed |
| Broadening horizons: new links between cilia and heart development and disease. | Front Cardiovasc Med | 2026 | 41783016 | PubTator, text mining | PubMed |
| ELABELA: A Potential Therapeutic Target for Ischemia-Reperfusion Injury. | Biomolecules | 2026 | 41750369 | PubTator, text mining | PubMed |
| Renal Aspects of the Apelinergic System: Therapeutic Potential and Mechanisms. | Biomolecules | 2026 | 41750255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=2